Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|133|4|261-269

ISSN： 1660-8151

Source： Nephron, Vol.133, Iss.4, 2016-07, pp. : 261-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer in End-Stage Renal Disease: Potential Factors Involved

By  

American Journal of Nephrology, Vol. 18, Iss. 2, 1998-04 ,pp. : 89-95

Karger

Access to resources Recommend Favorite

Thioredoxin-Interacting Protein: A Potential Therapeutic Target for Treatment of Progressive Fibrosis in Diabetic Nephropathy

By  

Nephron, Vol. 129, Iss. 2, 2015-01 ,pp. : 109-127

Karger

Access to resources Recommend Favorite

Prevalence of the Janus Kinase 2 V617F Mutation in Patients with End-Stage Renal Disease

By  

Nephron, Vol. 135, Iss. 3, 2016-11 ,pp. : 242-242

Karger

Access to resources Recommend Favorite

Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models

By  

Cardiorenal Medicine, Vol. 1, Iss. 3, 2011-06 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Identifying Chemokines as Therapeutic Targets in Renal Disease: Lessons from Antagonist Studies and Knockout Mice

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 4, 2004-09 ,pp. : 226-238

Karger

Access to resources Recommend Favorite